H Volz

Summary

Affiliation: Friedrich Schiller University
Country: Germany

Publications

  1. ncbi High-energy phosphates in the frontal lobe correlate with Wisconsin Card Sort Test performance in controls, not in schizophrenics: a 31phosphorus magnetic resonance spectroscopic and neuropsychological investigation
    H P Volz
    Department of Psychiatry, University of Jena, Germany
    Schizophr Res 31:37-47. 1998
  2. ncbi Monoamine oxidase inhibitors. A perspective on their use in the elderly
    H P Volz
    Hans Berger Kliniken, Klinik fur Psychiatrie, Friedrich Schiller Universitat Jena, Germany
    Drugs Aging 13:341-55. 1998
  3. ncbi Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial
    H P Volz
    Psychiatric Department, Friedrich Schiller Universitat Jena, Philosophenweg 3, D 07740, Jena, Germany
    Eur Neuropsychopharmacol 10:211-7. 2000
  4. ncbi Supporting evidence for the model of cognitive dysmetria in schizophrenia--a structural magnetic resonance imaging study using deformation-based morphometry
    H Volz
    Psychiatric Department, University of Jena, Philosophenweg 3, D 07740, Jena, Germany
    Schizophr Res 46:45-56. 2000
  5. ncbi [Phytochemicals as means to induce sleep]
    H P Volz
    Psychiatrische Klinik der Friedrich Schiller Universität Jena
    Z Arztl Fortbild Qualitatssich 95:33-4. 2001
  6. ncbi Reboxetine and cytochrome P450--comparison with paroxetine treatment in humans
    U D Kuhn
    Institute of Clinical Pharmacology, Friedrich Schiller University, Jena, Germany
    Int J Clin Pharmacol Ther 45:36-46. 2007
  7. ncbi [Psychiatric comorbidity in somatic disorders. Psychophytopharmaceuticals are worth a try]
    H P Volz

    MMW Fortschr Med 143:62-6. 2001
  8. ncbi Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis
    M Ufer
    Institute of Pharmacology, University Hospital Schleswig Holstein, Kiel, Germany
    Pharmacoepidemiol Drug Saf 16:1153-60. 2007

Detail Information

Publications8

  1. ncbi High-energy phosphates in the frontal lobe correlate with Wisconsin Card Sort Test performance in controls, not in schizophrenics: a 31phosphorus magnetic resonance spectroscopic and neuropsychological investigation
    H P Volz
    Department of Psychiatry, University of Jena, Germany
    Schizophr Res 31:37-47. 1998
    ..This association was not found in schizophrenics, possibly due to the influence of neuroleptic medication or the disease process per se...
  2. ncbi Monoamine oxidase inhibitors. A perspective on their use in the elderly
    H P Volz
    Hans Berger Kliniken, Klinik fur Psychiatrie, Friedrich Schiller Universitat Jena, Germany
    Drugs Aging 13:341-55. 1998
    ..Although orthostatic hypotension occurs in most patients treated with traditional MAOIs, the incidence in elderly patients with depression does not appear to be greater than that reported with tricyclic antidepressants...
  3. ncbi Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial
    H P Volz
    Psychiatric Department, Friedrich Schiller Universitat Jena, Philosophenweg 3, D 07740, Jena, Germany
    Eur Neuropsychopharmacol 10:211-7. 2000
    ..A similar number of adverse events was noted in both groups. The results of this first-placebo-controlled study in somatoform disorders suggest efficacy of opipramol in this indication but need replication...
  4. ncbi Supporting evidence for the model of cognitive dysmetria in schizophrenia--a structural magnetic resonance imaging study using deformation-based morphometry
    H Volz
    Psychiatric Department, University of Jena, Philosophenweg 3, D 07740, Jena, Germany
    Schizophr Res 46:45-56. 2000
    ..This highlights the importance of this concept for future investigations...
  5. ncbi [Phytochemicals as means to induce sleep]
    H P Volz
    Psychiatrische Klinik der Friedrich Schiller Universität Jena
    Z Arztl Fortbild Qualitatssich 95:33-4. 2001
    ..However, no sleep inducing potential of valerian was observed, only a certain positive effect on daytime mood. Therefore, the mentioned phytopharmacons cannot be recommended for the treatment of sleep disturbances...
  6. ncbi Reboxetine and cytochrome P450--comparison with paroxetine treatment in humans
    U D Kuhn
    Institute of Clinical Pharmacology, Friedrich Schiller University, Jena, Germany
    Int J Clin Pharmacol Ther 45:36-46. 2007
    ..Thus, in this study the pharmacokinetics of reboxetine in relation to pharmacogenetics and the effects of reboxetine compared to paroxetine treatment on the CYP2D6 and CYP3A4 phenotype were analyzed in healthy control subjects...
  7. ncbi [Psychiatric comorbidity in somatic disorders. Psychophytopharmaceuticals are worth a try]
    H P Volz

    MMW Fortschr Med 143:62-6. 2001
    ..At present, no herbal preparation can be recommended for the treatment of sleep disorders, as no unequivocal proof of efficacy in patients with such problems has yet been established...
  8. ncbi Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis
    M Ufer
    Institute of Pharmacology, University Hospital Schleswig Holstein, Kiel, Germany
    Pharmacoepidemiol Drug Saf 16:1153-60. 2007
    ..Therefore, we have identified patterns and prevalence of antidepressant use among outpatients on a population-based scale in the German state of Baden-Wuerttemberg...